Cardiac resynchronization therapy: need to synchronize patients and device longevities with comorbidities

Europace. 2019 May 1;21(5):683-685. doi: 10.1093/europace/euy297.

Authors

Giuseppe Boriani¹, Marco Vitolo¹, Valentina Kutyifa^{2

3}

Affiliations

¹ Division of Cardiology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
² Clinical Cardiovascular Research Center, University of Rochester Medical Center, 265 Crittenden Blvd., Box 653, Rochester, NY, USA.
³ Department of Cardiology, Heart Center, Semmelweis University, Budapest, Hungary.

PMID: 30590486
DOI: 10.1093/europace/euy297

No abstract available

Publication types

Comment

MeSH terms

Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy*
Comorbidity
Defibrillators, Implantable*
Humans